AR and prostate cancer: In prostate cancer, NEU3 upregulation activated androgen receptor (AR) signaling by increasing early growth response gene-1, AR, and prostate-specific antigen expression, possibly via EGFR family activation, presumably via modulation of GM3 into LacCer; this can result in androgen-independent cancer cell proliferation [37].